| |
| |
|
| Insider
Information: |
Sandercock Colin |
| Relationship: |
SVP, General Counsel a... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
17,125 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,333 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
17,125 |
|
|
| Total
Value |
$37,333 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cue Biopharma, Inc. |
CUE |
SVP, General Counsel a... |
2020-08-05 |
17,125 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4/A |
AS |
$20.00 |
$267,480 |
D/D |
(13,374) |
17,125 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4/A |
OE |
$7.50 |
$100,305 |
D/D |
13,374 |
30,499 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4 |
AS |
$20.00 |
$265,480 |
D/D |
(13,274) |
17,125 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4 |
OE |
$7.50 |
$99,555 |
D/D |
13,274 |
30,399 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-04 |
4 |
AS |
$20.05 |
$4,030 |
D/D |
(201) |
17,125 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-04 |
4 |
OE |
$7.50 |
$1,508 |
D/D |
201 |
17,326 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-03 |
4 |
AS |
$20.00 |
$128,500 |
D/D |
(6,425) |
17,125 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2020-08-03 |
4 |
OE |
$7.50 |
$48,188 |
D/D |
6,425 |
23,550 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2019-06-10 |
4/A |
B |
$7.90 |
$118,698 |
D/D |
15,025 |
17,125 |
2.74 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2019-06-10 |
4 |
B |
$7.93 |
$118,458 |
D/D |
14,938 |
16,938 |
2.74 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2019-06-07 |
4/A |
B |
$7.35 |
$735 |
D/D |
100 |
2,100 |
2.66 |
- |
|
| CUE |
Cue Biopharma, Inc. |
SVP, General Counsel and Sec |
• – – |
2019-06-06 |
4 |
B |
$7.10 |
$14,200 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
